Economic Rules Hub
  • World
  • Politics
  • Business
  • Investing
Home Politics HHS SEC ROBERT F KENNEDY JR: American patients pay more so others can pay less — that stops now
Politics

HHS SEC ROBERT F KENNEDY JR: American patients pay more so others can pay less — that stops now

by admin May 17, 2025
May 17, 2025
NEWYou can now listen to Fox News articles!

President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations.

Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after manufacturer discounts to insurers, Americans still pay over $400—for the identical medication, from the same company, produced in the same facility. This disparity is especially galling when pharmaceutical companies extract 70% of their profits from America—a nation representing just 4% of the world’s population. This global free-riding on American patients ends now.

Industry leaders recognize this imbalance. I’ve already engaged with CEOs from four major American pharmaceutical companies and a foreign manufacturer eager to relocate to the U.S. Their response has been encouraging, but we’re prepared to act decisively if necessary. U.S. Health and Human Services and Centers for Medicare & Medicaid Services (CMS) possess the statutory authority to deliver on President Trump’s commitment: other developed nations must pay more, so Americans can pay less, thus preserving the innovation pipeline.

Americans deserve both groundbreaking therapies and affordable access to them. Yet according to the Kaiser Family Foundation, nearly one-third of patients skip prescribed medications due to cost—an unacceptable reality in the world’s wealthiest nation.

While prevention through healthier lifestyles remains our best strategy for reducing medication dependence, certain treatments will always be essential. The pharmaceutical industry has delivered remarkable advancements in cancer and autoimmune therapies that benefit patients worldwide. 

We value continued innovation as a core American principle, but we cannot indefinitely subsidize global medical progress while other wealthy nations contribute disproportionately little.

President Trump’s negotiation approach has already proven effective with NATO, where European countries responded to accountability by making historic reinvestments that strengthened the alliance. The same principle applies here. The President and I stand united: global free riding on American patients must end.

CMS, with Dr. Mehmet Oz at the helm, extends beyond payment reform to fundamentally realigning care delivery incentives. This initiative will protect safety nets for vulnerable populations while addressing the financial pressures facing state partners and federal programs—particularly Medicaid, which has seen dramatic growth in both enrollment and costs.

The coming months will be decisive in achieving President Trump’s prescription for a healthier America—one where innovation thrives, and patients no longer shoulder an unfair share of the global healthcare burden.

This post appeared first on FOX NEWS

0
FacebookTwitterPinterestEmail
previous post
Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.
next post
Biden fails to remember when son Beau died and Trump’s election year in leaked Hur interview audio

Related Posts

GOP bill takes aim at Congress’ ‘no rules apply’ emergency...

June 6, 2025

Musk says Trump would have lost 2024 election without him...

June 6, 2025

White House highlights Pelosi hypocrisy after Schiff demands Trump admin financial, ethics...

June 6, 2025

Ex-Biden advisor calls Jean-Pierre ‘kinda dumb,’ deletes tweet, says she’s...

June 6, 2025

Musk unleashes wild Epstein claim against Trump after being booted...

June 6, 2025

Trump administration defends US and Israeli sovereignty with new sanctions...

June 6, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • What we know about the countries on Trump’s travel ban list, and how many people will be impacted

      June 6, 2025
    • Israel strikes southern suburb in Beirut

      June 6, 2025
    • What is D-Day? How the Normandy landings led to Germany’s defeat in World War II

      June 6, 2025
    • Russia launches aerial assault on Kyiv days after Ukraine’s audacious drone attack on bomber fleet

      June 6, 2025
    • North Korea refloats destroyer that capsized during launch, surprising naval analysts

      June 6, 2025

    Categories

    • Business (1,393)
    • Investing (3,399)
    • Politics (4,546)
    • World (4,458)
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy
    • Contacts
    • About us

    Disclaimer: EconomicRulesHub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 EconomicRulesHub.com | All Rights Reserved

    Economic Rules Hub
    • World
    • Politics
    • Business
    • Investing